Retraction: Monocrotophos induces the expression and activity of xenobiotic metabolizing enzymes in pre-sensitized cultured human brain cells (PLoS ONE (2014) 9: 3 (e91946) DOI: 10.1371/journal.pone.0091946);Monocrotophos induces the expression and activity of xenobiotic metabolizing enzymes in pre-sensitized cultured human brain cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Tripathi, Vinay K ^a,c   Kumar, Vivek ^a,c   Singh, Abhishek K ^a   Kashyap, Mahendra P ^a   Jahan, Sadaf ^a   Pandey, Ankita ^a   Alam, Sarfaraz ^b   Khan, Feroz ^b   Khanna, Vinay K ^a   Yadav, Sanjay ^a   Lohani, Mohtshim ^c   Pant, Aditya B ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^c INTEGRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALCOHOL; AROMATIC HYDROCARBON RECEPTOR; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2B6; CYTOCHROME P450 2E1; MONOCROTOPHOS; NEUROTOXIN; XENOBIOTIC AGENT;

ARTICLE; BRAIN CELL; BRAIN CELL CULTURE; BRAIN FUNCTION; CATALYSIS; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MOLECULAR DOCKING; NEUROTOXICITY; NEUROTRANSMISSION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; XENOBIOTIC METABOLISM; BIOCATALYSIS; BRAIN; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN CONFORMATION; TOXICITY; TUMOR CELL LINE;

BIOCATALYSIS; BRAIN; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR DOCKING SIMULATION; MONOCROTOPHOS; NEUROTOXINS; PROTEIN CONFORMATION; TRANSCRIPTION, GENETIC; XENOBIOTICS;

EID: 84899725385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0214164     Document Type: Erratum

References (78)

1. Johansson I, Ingelman-Sundberg M (2011) Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci 120: 1-13.
2. Turesky RJ, Le Marchand L (2011) Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol 24: 1169-1214.
3. Antherieu S, Chesne C, Li R, Camus S, Lahoz A, et al. (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38: 516-525.
4. Ferguson CS, Tyndale RF (2011) Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32: 708-714.
5. Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, et al. (2009) Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37: 1528-1538.
6. Ravindranath V, Strobel HW (2013) Cytochrome P450-mediated metabolism in brain: functional roles and their implications. Expert Opin Drug Metab Toxicol 9: 551-558.
7. Miksys S, Tyndale RF (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 36: 313-333. (Pubitemid 38802491)
8. Miksys S, Tyndale RF (2009) Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology 34: 634-640.
9. Johri A, Yadav S, Dhawan A, Parmar D (2008) Responsiveness of cerebral and hepatic cytochrome P450s in rat offspring prenatally exposed to lindane. Toxicol Appl Pharmacol 231: 10-16.
10. Miksys S, Tyndale RF (2006) Nicotine induces brain CYP enzymes: relevance to Parkinson's disease. J Neural Transm Suppl: 177-180. (Pubitemid 44622197)
11. Meyer RP, Gehlhaus M, Knoth R, Volk B (2007) Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab 8: 297-306. (Pubitemid 46780059)
12. Kapoor N, Pant AB, Dhawan A, Dwievedi UN, Seth PK, et al. (2006) Cytochrome P450 1A isoenzymes in brain cells: Expression and inducibility in cultured rat brain neuronal and glial cells. Life Sci 79: 2387-2394. (Pubitemid 44772937)
13. Kapoor N, Pant AB, Dhawan A, Dwievedi UN, Gupta YK, et al. (2006) Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol. Life Sci 79: 1514-1522. (Pubitemid 44339546)
14. Kapoor N, Pant AB, Dhawan A, Dwievedi UN, Seth PK, et al. (2007) Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells. Mol Cell Biochem 305: 199-207. (Pubitemid 47517182)
15. Singh AK, Kashyap MP, Jahan S, Kumar V, Tripathi VK, et al. (2012) Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci 129: 392-410.
16. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, et al. (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107: 1518-1528.
17. Ghosh C, Gonzalez-Martinez J, Hossain M, Cucullo L, Fazio V, et al. (2010) Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow. Epilepsia 51: 1408-1417.
18. Kumar S (2010) Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation. Expert Opin Drug Metab Toxicol 6: 115-131.
19. Ingelman-Sundberg M, Sim SC (2010) Intronic polymorphisms of cytochromes P450. Hum Genomics 4: 402-405.
20. Khokhar JY, Tyndale RF (2011) Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects. Neuropsychopharmacology 36: 692-700.
21. Gilot D, Le Meur N, Giudicelli F, Le Vee M, Lagadic-Gossmann D, et al. (2011) RNAi-based screening identifies kinases interfering with dioxin-mediated upregulation of CYP1A1 activity. PLoS One 6: e18261.
22. Niestroy J, Barbara A, Herbst K, Rode S, van Liempt M, et al. (2011) Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro 25: 671-683.
23. Gu J, Horikawa Y, Chen M, Dinney CP, Wu X (2008) Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 17: 2445-2450.
24. Stejskalova L, Dvorak Z, Pavek P (2011) Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr Drug Metab 12: 198-212.
25. Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF (2003) Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 45: 122-132. (Pubitemid 36700458)
26. Howard LA, Miksys S, Hoffmann E, Mash D, Tyndale RF (2003) Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol 138: 1376-1386. (Pubitemid 36543136)
27. Mo SL, Liu YH, Duan W, Wei MQ, Kanwar JR, et al. (2009) Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr Drug Metab 10: 730-753.
28. Seliskar M, Rozman D (2007) Mammalian cytochromes P450-importance of tissue specificity. Biochim Biophys Acta 1770: 458-466. (Pubitemid 46136750)
29. Bromek E, Haduch A, Daniel WA (2010) The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Eur J Pharmacol 626: 171-178.
30. Ekins S, Iyer M, Krasowski MD, Kharasch ED (2008) Molecular characterization of CYP2B6 substrates. Curr Drug Metab 9: 363-373. (Pubitemid 352025191)
31. Zanger UM, Turpeinen M, Klein K, Schwab M (2008) Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 392: 1093-1108.
32. Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, Ingelman-Sundberg M (2010) Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet 127: 1-17.
33. Sanchez-Catalan MJ, Hipolito L, Guerri C, Granero L, Polache A (2008) Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat. Alcohol Alcohol 43: 401-407. (Pubitemid 351965908)
34. Meyer RP, Gehlhaus M (2010) A role for CYP in the drug-hormone crosstalk of the brain. Expert Opin Drug Metab Toxicol 6: 675-687.
35. Novak RF, Woodcroft KJ (2000) The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res 23: 267-282.
36. Kessova I, Cederbaum AI (2003) CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med 3: 509-518. (Pubitemid 37168595)
37. Hipolito L, Sanchez MJ, Polache A, Granero L (2007) Brain metabolism of ethanol and alcoholism: an update. Curr Drug Metab 8: 716-727. (Pubitemid 47578120)
38. Chandrasekaran K, Swaminathan K, Chatterjee S, Dey A (2010) Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro 24: 387-396.
39. Trafalis DT, Panteli ES, Grivas A, Tsigris C, Karamanakos PN (2010) CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol 6: 307-319.
40. Pal D, Kwatra D, Minocha M, Paturi DK, Budda B, et al. (2011) Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sci 88: 959-971.
41. Zimatkin SM, Pronko SP, Vasiliou V, Gonzalez FJ, Deitrich RA (2006) Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res 30: 1500-1505. (Pubitemid 44272739)
42. Baillie TA, Rettie AE (2011) Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 26: 15-29.
43. Cederbaum AI, Wu D, Mari M, Bai J (2001) CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 31: 1539-1543. (Pubitemid 34024976)
44. Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49: 57-71.
45. Singh S, Ranjit A, Parthasarathy S, Sharma N, Bambery P (2004) Organophosphate induced delayed neuropathy: report of two cases. Neurol India 52: 525-526. (Pubitemid 40110594)
46. Singh M, Sandhir R, Kiran R (2004) In vitro effects of organophosphate pesticides on rat erythrocytes. Indian J Exp Biol 42: 292-296. (Pubitemid 38318879)
47. Masoud A, Kiran R, Sandhir R (2009) Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats. Cell Mol Neurobiol 29: 1245-1255.
48. Kashyap MP, Singh AK, Siddiqui MA, Kumar V, Tripathi VK, et al. (2010) Caspase cascade regulated mitochondria mediated apoptosis in monocrotophos exposed PC12 cells. Chem Res Toxicol 23: 1663-1672.
49. Kashyap MP, Singh AK, Kumar V, Tripathi VK, Srivastava RK, et al. (2011) Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s. PLoS One 6: e17757.
50. Shao J, Stapleton PL, Lin YS, Gallagher EP (2007) Cytochrome p450 and glutathione s-transferase mRNA expression in human fetal liver hematopoietic stem cells. Drug Metab Dispos 35: 168-175. (Pubitemid 46043233)
51. Schagger H (2006) Tricine-SDS-PAGE. Nat Protoc 1: 16-22.
52. Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55: 416-421.
53. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201. (Pubitemid 43205406)
54. Patel S, Bajpayee M, Pandey AK, Parmar D, Dhawan A (2007) In vitro induction of cytotoxicity and DNA strand breaks in CHO cells exposed to cypermethrin, pendimethalin and dichlorvos. Toxicol In Vitro 21: 1409-1418. (Pubitemid 350086860)
55. Johri A, Yadav S, Singh RL, Dhawan A, Ali M, et al. (2006) Long lasting effects of prenatal exposure to deltamethrin on cerebral and hepatic cytochrome P450s and behavioral activity in rat offspring. Eur J Pharmacol 544: 58-68. (Pubitemid 44148581)
56. Sjogren E, Svanberg P, Kanebratt KP (2012) Optimized experimental design for the estimation of enzyme kinetic parameters: an experimental evaluation. Drug Metab Dispos 40: 2273-2279.
57. Kazi AI, Oommen A (2012) The effect of acute severe monocrotophos poisoning on inhibition, expression and activity of acetylcholinesterase in different rat brain regions. Neurotoxicology 33: 1284-1290.
58. Junior HV, de Franca Fonteles MM, Mendes de Freitas R (2009) Acute seizure activity promotes lipid peroxidation, increased nitrite levels and adaptive pathways against oxidative stress in the frontal cortex and striatum. Oxid Med Cell Longev 2: 130-137.
59. Kaur P, Radotra B, Minz RW, Gill KD (2007) Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 28: 1208-1219. (Pubitemid 350026599)
60. Galluzzi L, Blomgren K, Kroemer G (2009) Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10: 481-494.
61. Aleksunes LM, Klaassen CD (2012) Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. Drug Metab Dispos 40: 1366-1379.
62. Aguiar M, Masse R, Gibbs BF (2005) Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 37: 379-404. (Pubitemid 40677509)
63. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, et al. (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79: 1045-1052.
64. Shahabi HN, Andersson DR, Nissbrandt H (2008) Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse 62: 379-388. (Pubitemid 351451806)
65. Nissbrandt H, Bergquist F, Jonason J, Engberg G (2001) Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 40: 294-301. (Pubitemid 32396413)
66. Miksys S, Tyndale RF Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci 37: 120133.
67. Kirby, M. L.; Castagnoli, K.; Bloomquist, J. R., In vivo effects of deltamethrin on dopamine neurochemistry and the role of augmented neurotransmitter release. Pesticide Biochemistry and Physiology 1999, 65, 160-168.
68. Franco R, Li S, Rodriguez-Rocha H, Burns M, Panayiotidis MI (2010) Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease. Chem Biol Interact 188: 289-300.
69. Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, et al. (2004) Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem 91: 285-298. (Pubitemid 39363428)
70. Dayal M, Parmar D, Dhawan A, Ali M, Dwivedi UN, et al. (2003) Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food Chem Toxicol 41: 431-437. (Pubitemid 36015780)
71. Slotkin TA, Tate CA, Cousins MM, Seidler FJ (2002) Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res 133: 163-173. (Pubitemid 34212001)
72. Jeffrey P, Summerfield S Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol Dis 37: 33-37.
73. Konstandi M, Kostakis D, Harkitis P, Marselos M, Johnson EO, et al. (2005) Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochem Pharmacol 69: 277-287. (Pubitemid 41556574)
74. Meyer RP, Knoth R, Schiltz E, Volk B (2001) Possible function of astrocyte cytochrome P450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures. Exp Neurol 167: 376-384. (Pubitemid 32150895)
75. Malaplate-Armand C, Leininger-Muller B, Batt AM (2004) [Astrocytic cytochromes p450: an enzyme subfamily critical for brain metabolism and neuroprotection]. Rev Neurol (Paris) 160: 651-658.
76. Takahashi S, Izawa Y, Suzuki N (2012) Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia. Rinsho Shinkeigaku 52: 41-51.
77. Murphy TH, Yu J, Ng R, Johnson DA, Shen H, et al. (2001) Preferential expression of antioxidant response element mediated gene expression in astrocytes. J Neurochem 76: 1670-1678. (Pubitemid 32221107)
78. Hagemeyer CE, Rosenbrock H, Ditter M, Knoth R, Volk B (2003) Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 117: 521-529. (Pubitemid 36263148) Science and Technology Science and Technology